Abiopharma

(100% Positive) Rockwell Medical Inc. (RMTI) Reports Q1 2026 Financial Results

(61% Neutral) RAPT Therapeutics Inc (RAPT) Announces Business Combination

New Form SCHEDULE 13G - Adlai Nortye Ltd. Filed: 2026-01-20 AccNo: 0000950103-26-000641 Size: 15 KB

Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

New Form EFFECT - SCWorx Corp. Filed: 2026-01-16 AccNo: 9999999995-26-000204 Size: 1 KB

New Form EFFECT - CollPlant Biotechnologies Ltd Filed: 2026-01-16 AccNo: 9999999995-26-000206 Size: 2 KB

New Form EFFECT - Tharimmune, Inc. Filed: 2026-01-16 AccNo: 9999999995-26-000208 Size: 1 KB

New Form EFFECT - AETHLON MEDICAL INC Filed: 2026-01-16 AccNo: 9999999995-26-000202 Size: 1 KB

New Form EFFECT - ALLURION TECHNOLOGIES, INC. Filed: 2026-01-16 AccNo: 9999999995-26-000210 Size: 1 KB

(99% Neutral) Avadel Pharmaceuticals (AVDL) Announces Business Combination

Natera - Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting

Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results

General Announcement: Press Release - iX Biopharma Named Among Singapores Fastest Growing Companies 2026

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016